Contraindicated (1)bortezomib will raise the amount or influence of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Powerful or reasonable CYP2C19 inhibitors may perhaps raise mavacamten systemic exposure, resulting in coronary heart failure due to systolic dysfunction. The sq. root of two may be the frequency ratio of a tritone https://sarolaner00987.blogtov.com/7238099/what-does-lp-pla2-in-1-mean